In recent years the stem cell science has increasingly focused on mitigating the loss of vision. Cell based therapies are showing tremendous promise in mitigating many acquired and hereditary vision problems. Age Related Macular Degeneration in particular is under scrutiny as a condition that is likely to respond to adult mesenchymal cell therapy.
Ophthalmology and Carolina Stem Cell Treatment Center
At Carolina Stem Cell Treatment Center and Cell Surgical Network, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) on various ophthalmologic conditions including Macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachments, Leber’s optic neuropathy and optic neuritis. In collaboration with our opthalmology consultants we have designed protocols for visual loss conditions that emphasize safety and efficacy. The CSCTC deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement . The entire cellular surgical procedure takes approximately 3 hours.
Ophthalmology Call to Action
We care about our Ophthalmology patients at Carolina Stem Cell Treatment Center an affiliate of CSN. We take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out the CSCTC Confidential Candidate Application, we will answer the questions and concerns you may have about CSCTC and CSN protocols for Ophthalmology.